• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Sudden cardiac death (SCD) is an unexpected sudden death due to a heart condition, that
occurs within one hour of symptoms onset. SCD is a leading cause of death in western …

Background: Acute myocardial injury in hospitalized patients with coronavirus disease 2019
(COVID-19) has a poor prognosis. Its associations and pathogenesis are unclear. Our aim …

There is increasing evidence regarding the prevalence of genetic cardiomyopathies, for
which arrhythmias may be the first presentation. Ventricular and atrial arrhythmias …

Background: Myocardial fibrosis is a common postmortem finding among individuals with
Sudden Cardiac Death (SCD). Numerous in vivo and in vitro studies have shown that …

Aim To compare the risk of ventricular arrhythmias (VA) and sudden death (SD) between
New York Heart Association (NYHA) class I and NYHA class II–III patients with non …

Background Late gadolinium enhancement (LGE) is a widely used cardiac magnetic
resonance imaging (MRI) technique to diagnose a broad range of ischemic and non …

Dilated cardiomyopathy (DCM) represents one of the most common causes of non-ischemic
heart failure, characterised by ventricular dilation alongside systolic dysfunction. Despite …

Myocardial fibrosis is defined as an increased amount of collagen in the myocardium
relative to cardiac myocytes. Two main morphologic patterns are recognized: 1) replacement …

Objectives: To analyze the association between global myocardial work indices evaluated
by non-invasive left ventricular (LV) pressure-strain loop (PSL) and LV myocardial fibrosis in …